Exane BNP Paribas analyst Nate Crossett initiated coverage of Medical Properties Trust with a Neutral rating and $5.50 price target.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MPW:
- Medical Properties (NYSE:MPW) Sells Four Australian Sites for $305M
- Medical Properties Trust put volume heavy and directionally bearish
- Medical Properties Trust receives Australian FIRB approval of facility sale
- Medical Properties Trust price target lowered to $6 from $10 at Truist
- Largest borrow rate increases among liquid names